The Next Generation Colposcope with an Advanced Cervical Scan

DYSISmap is an adjunctive technology to assist colposcopy

The DYSIS Colposcope is a high resolution digital colposcope with an adjunctive map. The DYSISmap is generated by a proprietary technology that measures the aceto-whitening reaction and summarises it in the form of an intuitive map. The DYSISmap is overlaid on the live image of the cervix to help with the identification of the most relevant biopsy sites.

14 December, 2016

Johns Hopkins adopts DYSIS Advanced Cervical Imaging

Edinburgh, U.K. – December 14, 2016 – DYSIS Medical, Ltd. announced today that the Johns Hopkins Department of Gynaecology and Obstetrics became the 100th site to purchase the DYSIS Advanced Cervical Imaging System – a next-generation colposcope with proprietary software tools used to assess women for […]

More >

30 November, 2016

DYSIS featured on television

DYSIS technology has been hailed a “game changer” in the detection of cervical cancer. Orlando News6 features DYSIS and interviews Doctors who have integrated it into their practice. Watch the video here:     Source : www.clickorlando.com

More >

26 September, 2016

Women’s Care Florida among first 100 DYSIS users in USA

Women’s Care Florida among first 100 U.S. OB-GYN practices implementing advanced cervical imaging technology First locations in Tampa Bay to standardize colposcopy after abnormal Pap smears     Edinburgh, UK, September 26, 2016 – DYSIS Medical Ltd. (DYSIS), an innovative women’s health company, announced today […]

More >

22 September, 2016

Arizona Oncology implements DYSIS

Arizona Oncology implements advanced cervical imaging technology to assist with the early detection of cervical cancer September 28th is National Women’s Health and Fitness Day and women are encouraged to take control of their health Scottsdale, Ariz. (September 22, 2016) – Arizona Oncology, one of […]

More >

12 May, 2016

First Data from largest colposcopy trial

EDINBURGH, UK (PRWEB) MAY 12, 2016 DYSIS Medical Ltd. (DYSIS), an innovative women’s health company that offers a new cervical imaging technology (dynamic spectral imaging) for women with abnormal Pap smears, announced today it will present initial findings from the IMproved PRactice Outcomes and Value […]

More >

13 April, 2016

DYSIS Announces Preliminary Findings From Largest U.S. Colposcopy Community Study at ASCCP 2016

Three abstracts presenting data from the study have been selected for poster presentations     TAMPA, Fla., April 12, 2016 – DYSIS Medical, a leading medical device company active in women’s health, announced today that three abstract submissions to the 2016 Annual Meeting of the American […]

More >

1 March, 2016

DYSIS Medical Signs Significant Deal

DYSIS Medical Signs Significant Deal with ITEM Medical Technologies to Support National Screening Programme in Turkey   DYSIS Colposcope to be incorporated into national cervical screening programme   Edinburgh, UK – 1 March 2016− DYSIS Medical Ltd. (DYSIS) today announces that it has signed a […]

More >

19 February, 2016

Four Abstracts selected for UK conference

Four separate abstracts have been selected for the forthcoming BSCCP conference being held at Bradford on April 13th. The topics are: Title: DYSIS service evaluation in Wales. Patient and colposcopist feedback. Presenting Author: Srividhya Budithi DYSIS service evaluation in Wales. Final data from 5 sites. Presenting […]

More >

15 February, 2016

Abstracts selected for US conferences

Two abstracts presenting data from the IMPROVE-COLPO study have been accepted for poster presentations at this year’s ASCCP annual meeting (New Orleans, April 13-16). These are the first results of the use of DYSIS on US patients to be presented to the community. The first […]

More >